Effector Therapeutics Competitors and Similar CompaniesClear all
Effector Therapeutics's competitors and similar companies include ImmunoGen, Aptevo Therapeutics, Olema Oncology and Scorpion Therapeutics.
 Effector Therapeutics Effector Therapeutics is a company focused on the discovery and development of small molecule cancer therapeutics. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | ||
Founding Date | Founding Date 2012 | Founding Date 1981 | Founding Date 2016 | Founding Date 2007 | Founding Date 2020 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Solana Beach, US HQ San Diego, US | Locations Waltham, US HQ | Locations Seattle, US HQ | Locations San Francisco, US HQ San Francisco, US | Locations Boston, US HQ Boston, US South San Francisco, US |
Employees | Employees 27 | Employees 277161% increase | Employees 1182% decrease | Employees 9630% increase | Employees 1213% decrease |
Valuation ($) | Valuation ($) 1.9 k | Valuation ($) 8.7 b | Valuation ($) 4.1 m | Valuation ($) 679.2 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($35.8m) (FY, 2023) | Net income ($222.9m) (FY, 2022) | Net income ($26m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 101m | Total funding raised $ 56m | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 108m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View companyAptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company
Scorpion Therapeutics
HQ
Boston, US
Employees
121↓ 3% decrease
Scorpion Therapeutics is a company that develops cancer treatments.
View company